My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1456

    1.

    Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling.

    Ando H, Izawa S, Hori W, Nakagawa I.

    Theor Biol Med Model. 2008 Aug 8;5:19. Erratum in: Theor Biol Med Model. 2009;6:29. PMID: 18687151 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

    Peters SA.

    Clin Pharmacokinet. 2008;47(4):261-75.PMID: 18336055 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.

    De Buck SS, Sinha VK, Fenu LA, Nijsen MJ, Mackie CE, Gilissen RA.

    Drug Metab Dispos. 2007 Oct;35(10):1766-80. Epub 2007 Jul 9.PMID: 17620347 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

    Oliver RE, Jones AF, Rowland M.

    J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):27-55.PMID: 11253612 [PubMed - indexed for MEDLINE]Related articles

    5.

    A novel strategy for physiologically based predictions of human pharmacokinetics.

    Jones HM, Parrott N, Jorga K, Lavé T.

    Clin Pharmacokinet. 2006;45(5):511-42.PMID: 16640456 [PubMed - indexed for MEDLINE]Related articles

    6.

    Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

    Rodgers T, Rowland M.

    J Pharm Sci. 2006 Jun;95(6):1238-57. Erratum in: J Pharm Sci. 2007 Nov;96(11):3153-4. PMID: 16639716 [PubMed - indexed for MEDLINE]Related articles

    7.

    Development and evaluation of a generic physiologically based pharmacokinetic model for children.

    Edginton AN, Schmitt W, Willmann S.

    Clin Pharmacokinet. 2006;45(10):1013-34.PMID: 16984214 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.

    Fagerholm U.

    J Pharm Pharmacol. 2007 Jun;59(6):803-28.PMID: 17637173 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data.

    Poirier A, Cascais AC, Funk C, Lavé T.

    Chem Biodivers. 2009 Nov;6(11):1975-87.PMID: 19937834 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.

    Fagerholm U.

    J Pharm Pharmacol. 2007 Oct;59(10):1427-31.PMID: 17910819 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.

    Poulin P, Theil FP.

    J Pharm Sci. 2002 May;91(5):1358-70.PMID: 11977112 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model.

    Björkman S, Wada DR, Berling BM, Benoni G.

    J Pharm Sci. 2001 Sep;90(9):1226-41.PMID: 11745776 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS.

    Gueorguieva I, Aarons L, Rowland M.

    J Pharmacokinet Pharmacodyn. 2006 Oct;33(5):571-94. Epub 2006 Jun 29.PMID: 16810558 [PubMed - indexed for MEDLINE]Related articles

    15.

    Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research.

    Tabata K, Hamakawa N, Sanoh S, Terashita S, Teramura T.

    Eur J Drug Metab Pharmacokinet. 2009 Apr-Jun;34(2):117-28.PMID: 19645221 [PubMed - indexed for MEDLINE]Related articles

    17.

    Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.

    Poirier A, Funk C, Scherrmann JM, Lavé T.

    Mol Pharm. 2009 Nov-Dec;6(6):1716-33.PMID: 19739673 [PubMed - indexed for MEDLINE]Related articles

    18.

    An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery.

    Parrott N, Paquereau N, Coassolo P, Lavé T.

    J Pharm Sci. 2005 Oct;94(10):2327-43.PMID: 16136543 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol-water partition coefficients.

    Ishizaki J, Yokogawa K, Nakashima E, Ichimura F.

    J Pharm Pharmacol. 1997 Aug;49(8):762-7.PMID: 9379352 [PubMed - indexed for MEDLINE]Related articles

    20.

    The prediction of drug metabolism, tissue distribution, and bioavailability of 50 structurally diverse compounds in rat using mechanism-based absorption, distribution, and metabolism prediction tools.

    De Buck SS, Sinha VK, Fenu LA, Gilissen RA, Mackie CE, Nijsen MJ.

    Drug Metab Dispos. 2007 Apr;35(4):649-59. Epub 2007 Jan 31.PMID: 17267621 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk